Qiagen buys two firms as focus shifts to Proteins

Qiagen acquires key assets of LumiCyte, which makes tools for protein analysis and SuNyx GmbH "On-Chip," Nanotechnology-Based Sample Preparation for LC-MALDI Mass Spectrometry.

Latest News and Financial Information | Reuters.com

BioBOOM Op/Ed: Nice purchases as they seem committed to investing heavily in the protein discovery and diagnostic areas lately. Only question is can they pull off a successful integration and keep the key personel needed long term. In the past, that's been their weakness.

No comments:

Blog Archive